Innervation is a fundamental basis for function and survival of tissues. In the peripheral tissues, degenerative diseases create a neurotoxic metabolic milieu that either causes neurodegeneration or fails to sustain regenerative growth and reinnervation of injured/diseased tissues. Encapsulation of cells producing neurotrophic factors can augment axon growth and neuron survival; however, sustained innervation in vivo requires a combination of factors promoting axon growth and guidance pathway that are released in a tissue-specific context. Using novel encapsulation techniques and genetic tools, we manipulated retinoic acidgenerating enzyme aldehyde dehydrogenase 1a1 ( 
INTRODUCTION

Neuronal damage
1,2 and neurodegeneration 3-5 impair central nervous system (CNS) function, they play critical role in the development and progression of metabolic disorders. 6, 7 Axons provide a template for vascularization. 8 In addition, axons integrate responses between peripheral tissues and the CNS. 9 Sympathetic innervation of white adipose tissue (WAT) controls essential metabolic processes such as lipolysis and energy dissipation by thermogenic adipocytes. 10, 11 Malfunctions in lipolysis and thermogenesis are associated with obesity. 12 Although the critical role for peripheral innervation in tissue homeostasis is well established, researchers still face considerable challenges in rebuilding axonal circuits after metabolic damage or injuries.
A significant challenge for rebuilding neuronal circuits is the failure of CNS axons to regenerate after injury. Peripheral nervous system (PNS) axons are capable of regeneration 13 and, therefore, represent a more viable target for regeneration therapies. Such therapies typically focus on improving neuron survival and enhancing axon growth.
14 Although PNS nerves can regenerate, 15 functional regeneration is often incomplete, due to decreased trophic support from peripheral cells. 16 One way to enhance the growth-supportive milieu for axons is to provide engineered encapsulating cells into preferred target sites. Cell encapsulation appears to be a safe and sustainable approach to deliver desirable compounds, such as nerve growth factor (NGF) or brain-derived neurotrophic factor, to the brain and other tissues. 17, 18 Although treatment with neurotrophic factors improves neuronal survival, it lacks other cues that guide axons and enable the formation of functional networks. These cues include axon guidance molecules (for attraction and repulsion), specific proteases, and other regulatory molecules responsible for regulation of G-protein-signaling cascades. 8 Together these cues allow for the formation of specific neuronal networks between peripheral tissues and the CNS. Because it is not conceivable to engineer cells to express all these molecules, it is critical to identify cells and/or regulatory pathways upstream of the production of axon guidance cues.
One such cell type is preadipocytes/fibroblasts. Preadipocytes have been identified as a common environment of peripheral vascular innervation. 19 Preadipocytes also play an important role in intracrine and paracrine regulation. Specifically, preadipocytes produce metabolites of vitamin A, such as retinoic acid (RA) and retinaldehyde (Rald) (Fig 1A) . 20 RA acts as a ligand for the RA receptor (RAR) and activates transcriptional or translational responses of RAR. 21 This receptor plays an important role in both thermogenesis and differentiation of neurons. [21] [22] [23] In preadipocytes and adipocytes, intracellular production of RA regulates adipogenesis and adipokine production. 21 In addition, RA could potentially regulate de novo neurogenesis from stromal cells in a paracrine fashion. 22 RAR activation in adipocytes depends on the aldehyde dehydrogenase 1 (ALDH1A1) enzyme. 20 Surprisingly, Aldh1a1 −/− -deficient mice producing 70% less RA in adipocytes 22 also exhibit increased thermogenesis in WAT. 24, 25 Whether increased thermogenesis in Aldh1a1 −/− mice is associated with improved sympathetic innervation is unknown. 11 Here, we identified a role for Aldh1a1 −/− preadipocytes in the production of axon guidance molecules in vivo and in vitro and established a connection between increased WAT innervation and metabolic rate in mice engrafted with Aldh1a1 
Background
Innervation is a fundamental basis for function and survival of tissues or implants. In the course of degenerative diseases, neurotoxic metabolic milieu leads to neurodegeneration that limits therapeutic approaches.
Translational Significance
Here, we identified a paracrine pathway dependent on retinoic acid-generating enzyme aldehyde dehydrogenase 1a1 (Aldh1a1) that inhibits axonal growth. We propose that encapsulation of Aldh1a1 −/− adipocytes into alginate poly-L-lysine microcapsules could provide a therapeutic solution for functional reinnervation of damaged or metabolically compromised tissues.
EXPERIMENTS AND METHODS
Animal studies. Animal studies were approved by the Institutional Animal Care and Use Committee of The Ohio State University (OSU). Data for all studies are summarized in Supplementary Table 1 . The exclusion criteria were the loss of more than 20% of weight in the course of the study; however, no animal was excluded from this study.
Randomization strategy. In studies 1 and 2, mice were randomized into age matching groups with similar percent of male and female mice. For proof-of-concept study 3, we used only age-matched female mice to match sex of implanted immortalized fibroblasts. Mice were randomly selected into control and treatment groups.
Study 1: WT and Aldh1a1
−/− mice on a high-fat (HF) diet. Aldh1a1 −/− deficient mice (C57BL/6J background) were developed and provided by G. Duester et al., 26 and their metabolic profile was described. 20, 24, [27] [28] [29] Matched C57BL/6 (WT) mice were used as control. C57BL/6J (WT) mice were initially purchased from The Jackson Laboratory (Bar Harbor, Maine) and then bred at OSU. Mice were fed a regular chow diet (Harlan Teklad, Madison, Wis). We used power analysis to determine the sample size of this study based on the data from the study 24 ; however, more animals were enrolled to complete all analysis.
WT and Aldh1a1 −/− were fed a HF diet (45% kcal from fat, D12451, Research Diet Inc, New Brunswick, NJ) for Aldh1a1 deficiency induces innervation in WAT in vivo without an increase in neural precursors. (A) Schematic of the main processes leading to production of retinoic acid (RA) in WAT. ALDH1A1 produces 70% of RA, which activates RAR in adipocytes (100%). 20 NGF plasma levels were examined by ELISA in WT and Aldh1a1
−/−
mice fed regular chow (B) or HF diet (C), n = 4 per group randomly selected from study 1 and 2. Relative expressions of Rbfox3 (D), Nestin (E), and Synapsin (F) were measured in iAb WAT from WT and Aldh1a1 −/− males (triangle, n = 5) and females (circle, n = 5) by TaqMan RT-PCR (HF, study 1). Expressions were normalized to Tata box protein (TBP). The levels of peripherin (G) and tyrosine hydroxylase (TH) (H) were analyzed by Western blot from randomly selected tissues of WT (n = 4) and Aldh1a1 −/− mice (n = 4) (HF, study 1). Protein expression was normalized by levels of housekeeping genes (β-actin). The insert shows representative Western blot. (I) Norepinephrine (NE) level from iAb fat pad homogenates in WT (n = 6) and Aldh1a1 −/− mice (n = 5) was measured using ELISA (HF diet, study 1). An asterisk indicates a significant difference between WT and Aldh1a1 −/− groups (P < 0.05). n.s.: not significant, Mann-Whitney U test. WAT, white adipose tissue; NGF, nerve growth factor; ELISA, enzyme-linked immunosorbent assay; WT, wild type.
180 days (8-month old at dissection) (numbers, sex, and weight are described in Supplementary Table 1) . Visceral (intra-abdominal [i-Ab]; gonadal) fat was collected for protein, mRNA, and histology. To omit a concern of heterogeneity of adipose tissue, regarding thermogenic/ lipogenic adipocyte composition and innervation, we used the whole fat pad for each analysis. For example, we used the left whole-fat pad for messenger RNA (mRNA) analysis and the right for the protein analysis. For histochemistry and norepinephrine (NE) extraction, we used another group of randomly selected animals from the same large study. The number of animals that were randomly selected for specific analysis was smaller than the number of animals in the whole group and is described in figure legends. ; therefore, we used females for this mechanistic proofof-concept study. Encapsulation into alginate-poly-Llysine is described in a detailed video protocol. 30 Eighteen 4-month-old WT female mice (C56BL/6J, The Jackson Laboratory, Bar Harbor, Maine, breed at OSU) were fed a HF diet for 220 days to induce obesity (N = 18; Supplementary Table 1 ). After that period, mice were randomly assigned into 4 groups: (1) injected with vehicle (1 mL sterile phosphate-buffered saline [PBS] solution, n = 5); (2) acellular "empty" capsules (n = 3); (3) encapsulated WT fibroblasts (0.5 × 10 6 cells in 1-mL PBS per iAb depot, n = 5); and (4) encapsulated Aldh1a1 −/− preadipocytes (0.5 × 10 6 cells in 1-mL PBS per iAb depot, n = 5). Mice were injected with vehicle or encapsulated cells into both iAb depots and maintained on the same HF diet for additional 80 days. The induction of thermogenesis by encapsulated Aldh1a1 −/− under these conditions is described in the study by Yang et al. 28 Whole iAb fat, which contains all encapsulated and host cells, was collected for protein analysis. Another iAb fat pad was embedded into paraffin for histologic examination of innervation.
Metabolic measurements. Metabolic parameters were measured by indirect calorimetry (Comprehensive Lab Animal Monitoring System; Columbus Instruments, Columbus, Ohio) at ambient temperature (22°C) with 12-h light/dark cycles. Animals were fed the same HF diet, and water was provided ad libitum. Mice were housed individually and allowed to acclimatize in the chambers for 12 h. Oxygen consumption, CO2 production, energy expenditure, and locomotor activity were measured for at least 24 h. Based on these data, respiratory quotient or exchange ratio (V CO2/VO2) and Δ heat values were calculated by Comprehensive Lab Animal Monitoring System.
Norepinephrine measurements. NE was measured in plasma and fat samples using Noradrenaline High Sensitive ELISA (EA633.96, Eagle Biosciences/DLD Diagnostika Hamburg, Germany) according to manufacturer's instructions. Hemolyzed blood samples were excluded as recommended by the manufacturer. For analysis, the whole fat pad (inguinal, i-Ab, or 2 brown fat pads) was homogenized using PBS.
Cell culture studies. Stromal vascular fraction (SVF) and immortalized cell line development. SVF was isolated from subcutaneous fat of one-month-old WT and Aldh1a1 −/− female mice fed regular chow as described. 24 Fibroblasts (preadipocytes) from SVF were immortalized using the protocol described in the study by Yang et al. 28 The phenotype of these cells was validated using Affimetrix gene microarray (described in the following). Full gene expression data set is uploaded as GEO file: "QS wild type and Aldh1a1 KO preadipocytes 2015".
Preparation and stimulation of adult mouse dorsal root ganglion (DRG) neurons.
Single-cell suspensions from cervical, thoracic, and lumbar DRG neurons were isolated from terminally anesthetized C57BL/6 adult female mice (aged 12-16 weeks, regular chow, The Jackson Laboratory). 31 Overall, 3 mice were purchased for DRG isolation, and these mice were not a part of other studies. Dissected DRGs were enzymatically digested in a solution of collagenase type 2 (200 U/mL; Sigma-Aldrich C6885, St. Louis, MO) and dispase I (5 U/mL; SigmaAldrich D4818) on a shaker for 45 min at 37°C. 31 Enzyme solution was aspirated, and cells were washed twice in Hank's Balanced Salt Solution 1x (HBSS; Mediatech Inc, Manassas, VA) before incubating in DNase I type II (5 mg/mL; Worthington Biochemical, Lakewood, NJ) for 5 min at room temperature. DRGs were triturated in HBSS with Pasteur pipette until cells were well dissociated, then passed through a Falcon 70-μm cell strainer (Corning Inc, Corning, NY) to remove myelin debris, after a 3-min centrifugation at 3000 rpm to pellet the cells. The neuron-enriched pellet was resuspended in DRG culture medium (DMEM/F12, 1% N2 supplement, and 0.05% gentamicin), and live cells were counted on a hemocytometer using trypan blue exclusion. Cells were plated at 500 cells/well in a 24-well plate (Corning Inc) previously coated with poly-D-lysine (25 μg/mL; SigmaAldrich P6407) and laminin (10 μg/mL; Thermo Fisher Scientific 23017015, Grand Island, NY). Each batch of DRG neurons were incubated at 37°C/5% CO2 in DRG culture medium only, DRG culture medium with NT-3 (1 ng/mL), with NGF (10 ng/mL), with WT secretome, with DRG medium (1:1, v/v), and with Aldh1a1 −/− secretome with DRG medium (1:1, v/v) for 24 hours. To assess neurite outgrowth and neuronal morphology, cells were fixed with 4% paraformaldehyde for 25 min 32 and washed in 0.1 M PBS, then incubated in blocking solution (4%BSA/0.3% Tx-100/PBS) for 1 hr at room temperature. Cells were immunostained with a monoclonal neuronal anti-β-tubulin III antibody (SigmaAldrich,T8578). Antibody was diluted in blocking solution (1:1000; at 4°C overnight), then washed and incubated in Alexa Fluor 546 secondary antibody (1:1000; Thermo Fisher Scientific Z25004) for 1 h at room temperature. Cells were automatically imaged using a Thermo Scientific ArrayScan XTI Live High Content microscope and analyzed with the Neuronal Profiling algorithm in the HCS Studio software (Thermo Fisher Scientific). 33 Total neurite length, average neurite length, number of branch points, critical value, dendrite maximum, and ramification index were averaged across all neurons detected per well, with 3 wells included per treatment. Three experimental replicates were performed using DRGs from 3 mice (total: n = 9). Dendrite maximum and critical value are parameters determined based on Sholl analysis. These values were automatically generated by the software. Dendrite maximum corresponds to the maximum number of dendrite crossings at a given radius from the cell body, and the critical value describes the radius at which the dendrite maximum occurs. The ramification index of a neuron is the dendrite maximum value divided by the number of primary dendrites. Percent of neurons with neurites was calculated as the ratio of the number of neurons with neurite extension to the total number of neurons per well. Significant growth differences were calculated in GraphPad Prism 5.0 (GraphPad Software) using well averages in a 1-way ANOVA followed by a Tukey post hoc analysis. Differences were significant for P < 0.05.
Adipocyte differentiation. Murine preadipocyte (3T3-L1, WT, and Aldh1a1 −/− ) lines were cultured and maintained in standard culture medium (DMEM containing 10% calf serum and 0.1% 50 mg/mL gentamicin). Adipogenesis was induced (day 0) in confluent preadipocytes using differentiation medium I containing 3-isobutyl-1-methylxanthine (0.5 mM), dexamethasone (1 μM), insulin (1.7 μM), 10% fetal bovine serum, and 0.1% gentamicin in DMEM. Differentiation medium II containing 10% fetal bovine serum, insulin (1.7 μM), and 0.1% gentamicin in DMEM was replaced every 48 h after adding differentiation medium I.
Gene expression analysis. Affymetrix GeneChip. mRNA was isolated by RNeasy (Qiagen, Valencia, Calif). RNA integrity was interrogated using an Agilent 2100 Bioanalyzer (Agilent Technologies). A 100-ng aliquot of total RNA was linearly amplified. Then, 5.5-μg of complementary DNA (cDNA) was labeled and fragmented using the GeneChip WT PLUS reagent kit (Affymetrix, Santa Clara, Calif) following the manufacturer's instructions. Labeled cDNA targets were hybridized to Affymetrix GeneChip Mouse Gene ST 2.0 arrays for 16 h at 45°C rotating at 60 rpm. The arrays were washed and stained using a Fluidics Station 450 and scanned using a GeneChip Scanner 3000. Signal intensities were quantified by Affymetrix Expression Console, version 1.3.1. Background correction and quantile normalization were performed to adjust for technical bias, and probe-set expression levels were calculated by the Robust MultiArray Analysis method. After filtering above the noise cutoff, there are 9528 probe sets that were tested by linear model. A variance smoothing method with fully moderated t statistic was employed for this study and was adjusted by controlling the mean number of false positives. With a combined cutoff of 2-fold change and P-value of 0.0001 (controlling 1 false positive over all probe sets), we declared 500 probe sets as differential gene expression between Aldh1a1 −/− and WT preadipocytes. GEO file: "QS wild type and Aldh1a1 KO preadipocytes 2015".
NanoString nCounter gene expression assay. NanoString's nCounter analysis (NanoString Technologies) system performed direct detection of target molecules from a single sample using color-coded molecular barcodes, giving a digital quantification of the number of target molecules as previously described. 34 A custom panel containing axon guidance molecules was designed and used for simultaneous quantification of 32 axon guidance genes and 5 housekeeping genes. All data were normalized to 5 housekeeping genes quantified in the same samples. Total mRNA (100 ng in 5 μL) was hybridized overnight with nCounter Reporter (20 μL) probes in hybridization buffer and in an excess of nCounter Capture probes (5 μL) at 65°C for [16] [17] [18] [19] [20] h. The hybridization mixture containing target/probe complexes was allowed to bind to magnetic beads containing complementary sequences on the capture probe. After each target found a probe pair, excess probes were washed followed by sequential binding to sequences on the reporter probe. Biotinylated capture probe-bound samples were immobilized and recovered on a streptavidin-coated cartridge. The abundance of specific target molecules was then quantified using the nCounter Digital Analyzer. Individual fluorescent barcodes and target molecules present in each sample were recorded with a CCD camera by performing a high-density scan (600 fields of view). Images were processed internally into a digital format and were normalized using the NanoString nSolver software analysis tool. Counts were normalized for all target RNAs in all samples based on the positive control RNA to account for differences in hybridization efficiency and posthybridization processing, including purification and immobilization of complexes. The average was normalized by background counts for each sample obtained from the average of the 8 negative control counts. Five internal reference housekeeping genes: Gapdh, Gusb, Hprt1, Pgk1, and Tubb were analyzed. Subsequently, a normalization of mRNA content was performed based on these genes, using nSolver Software.
Semi-quantitative mRNA analysis. mRNA was isolated from WAT or adipocyte cultures according to the manufacturer's instructions (Qiagen; Valencia, Calif). cDNA was prepared from purified mRNA and analyzed using a 7900HT Fast Real-Time PCR System, TaqMan fluorogenic detection system, and validated primers (Applied Biosystems, Foster City, Calif). Comparative real-time polymerase chain reaction was performed in triplicate, including no-template controls. The mRNA expression of genes of interest was normalized by Tata box protein or 18S expression level using the comparative cycle threshold method.
Protein analysis. Immunohistochemistry. Fat pads were embedded into paraffin for immunohistochemical analysis. Sections were stained with hematoxylin and eosin (H&E) using a modified hematoxylin procedure followed by dehydration in graded alcohol or with peripherin (Abcam, ab4666, Cambridge, Mass) and tyrosine hydroxylase polyclonal rabbit antibodies (Abcam, ab41528) at 1:1000 dilution. Images were obtained using Olympus M081 IX50 and Pixera Viewfinder 3.0 software.
Western blot. Cell/tissue protein lysates were normalized by protein content (bicinchoninic acid assay, Thermo Fisher Scientific). Medium was collected from cells, which were plated at similar numbers. Protein lysate or medium were separated on 10% acrylamide gel under reducing conditions. After transfer to a polyvinylidene fluoride membrane (Immobilon-P; Millipore), proteins were analyzed using an Odyssey Infrared Imaging System (LI-COR Biosciences). EFNA5 (Abcam, ab70114, Cambridge, Mass), peripherin, and tyrosine hydroxylase polyclonal rabbit antibodies (same as in immunohistochemistry) were used at 1:1000 dilution.
Enzyme-linked immunosorbent assay (ELISA). Plasma samples were collected from WT and Aldh1a1 −/− (A1KO) mice in the study 1-3. Adipose tissues were homogenized in radio immunoprecipitation assay buffer and used at same protein concentration (50 μg/mL). Medium was collected from differentiated and nondifferentiated 3T3-L1. Absorbance (450 nm) was measured using a Synergy H1 Hybrid Multi-Mode Microplate Reader. NGF ELISA was purchased from Abnova (KA0400,
−/− adipocytes and plasma from WT and Aldh1a1 −/− mice. Statistical analysis. Blinding statementThe mice treatment and collection of metabolic data and analysis of mRNA samples and immunohistochemistry was performed by different groups on coded samples. Human samples were obtained at Mayo clinic, and animal studies were performed by Ms. Shen and Dr. Yasmeen, who were responsible for the sample coding. The coded animals were placed in metabolic cages facility supervised by the department of physiology, and data were collected and digitalized. Messenger RNA and gene array were performed on coded samples at nucleic acid facility, and Dr. Fadda performed basic normalization on coded samples. Statistical analysis was performed by Dr. Yu at the statistical department, who was provided with the decoding information. Dr. Flechtner performed immunohistochemistry on coded samples. Ms. Marbourg performed DRG experiments and axon outgrowth for each condition without knowledge to treatment. Unbiased analyses of axon growth were conducted using software (HCS Studio software) associated with an automated high-content image analysis system.
All data are reported either as mean ± standard deviation (SD) or mean ± standard error of the mean (SEM). The number of samples is indicated in figure legends and Supplementary Table 1. Normal distribution was tested using Shapiro-Wilk test. Group comparisons were assessed using Mann-Whitney U test and/or ANOVA models or Kolmogorov-Smirnov test. All tests were 2-sided. P < 0.05 was considered to be statistically significant and is presented as asterisk (*). Trends were examined using Pearson correlation analysis tests.
RESULTS
Aldh1a1 in WAT creates a permissive environment for neural innervation. We investigated the cumulative impact of Aldh1a1 deficiency in peripheral innervation in mice adipose tissue. NGF was the first neurotrophic factor, which was described in adipocytes to be associated with obesity and vitamin A. [35] [36] [37] NGF levels in the circulation were similar in WT and Aldh1a1 −/− mice fed a regular ( Fig 1B, study 2) and a HF chow (HF, Fig 1C, study 1) . Next, we compared the expression of neuronal markers in WT and Aldh1a1 −/− male and female mice developing different WAT mass on a HF diet. The expression of Rbfox3 (Fig 1D) , a marker of the mature neurons, was similar in WAT of WT and Aldh1a1 −/− male and female mice on a HF diet. The expression of the neuronal precursor markers nestin (Fig 1E) and synapsin (Fig 1F) 20 and in the circulation. 38 Sprouting and growth of axons could increase innervation. 11 We observed higher protein expression in peripherin and tyrosine hydroxylase (TH), markers of peripheral and sympathetic neurons, respectively in Aldh1a1 −/− vs WT WAT (Fig 1, G and H) . The increased innervation was associated with significant higher levels of NE in WAT of Aldh1a1 −/− compared to WT mice (Fig 1I) −/− adipocytes was significantly more extensive than that seen in the presence of the classic inducers, NGF and NT3 (Fig 2,  A and B, larger numbers are shown in Supplementary  Fig 1) . Stimulation of primary murine DRG neurons with the medium obtained from differentiated Aldh1a1 −/− adipocytes led to a marked induction of axonal growth. We quantified axon growth by total length (Fig 2C) , average length (Fig 2D) , total branching points (Fig 2E) , dendrite maximum (Fig 2F) , as well as ramification index (Fig 2G) and critical values calculated from these parameters (Fig 2H) . All parameters showed that media from differentiated Aldh1a1 −/− adipocytes vs WT adipocytes markedly increased axon growth. Endogenous levels of NGF were present in low and equal amounts in the media from WT adipocytes and Aldh1a1 −/− adipocytes (0.1 ng/mL compared to 10 ng/mL of NGF used for positive control; Fig 2I) . Thus, molecules secreted from Aldh1a1 −/− adipocytes are neurotrophic and promote robust axon growth.
RA suppressed the positive regulation of axon growth by
Aldh1a1
−/− secretome. To test the role of RA in regulation of axon-guiding mediators in Aldh1a1 −/− adipocytes, we differentiated Aldh1a1 −/− preadipocytes in the presence or absence of RA. Then, we cultured naive primary DRG neurons in this medium. The RAconditioned Aldh1a1 −/− secretome inhibited the growth of DRG axons relative to the neurotrophic media from Aldh1a1 −/− adipocytes (Fig 3, A and B) . Thus, intracrine regulation of RA production from Rald by ALDH1A1 may be a mechanism by which adipocytes control innervation.
Aldh1a1 regulates genes involved in axon guidance. We compared genome of WT and Aldh1a1 −/− preadipocytes using gene microarray (Fig 4A) . Pathway analysis revealed that the primary pathway altered in Aldh1a1 −/− vs WT adipocytes was the axon guidance (Fig 4A) . Axon guidance pathway includes axon guidance molecules Efna5, Sema3d, Sema3e, their receptors, and coregulatory molecules Epha4, Slit1, Robo1, and Hhip. 39, 40 Axon growth is dependent on proteolysis that enables remodeling of matrix proteins and cleavage-dependent activation and secretion of ephrin ligands. 41, 42 Within the Aldh1a1 −/− -axon guidance pathway, there was significantly increased expression of mRNA encoding the proteases AdamtS9, matrix metallopeptidase 10 (Mmp10), and Mmp13 in Aldh1a1 −/− compared to WT adipocytes. The changes in expression of all these genes were validated using the quantitative nanostring approach (Fig  4B-E) .
To elucidate if Aldh1a1 could be involved in the cumulative regulation of genes responsible for axon guidance, we stimulated 3T3-L1 adipocytes with natural vitamin A metabolites controlled by this enzyme: (1) RA and (2) Rald, a RA precursor present in Aldh1a1 −/− adipocytes. 27 We also compared these responses to synthetic RAR agonist TTNPB and antagonist BMS493. We have found that Rald significantly induced the expression of Sema3e, AdamtS9, and Efna5 in 3T3-L1 adipocytes (Fig 4F) . However, the ability of Rald to induce the expression of Sema3e and AdamtS9 occurs independently of RAR agonists or antagonists ( Fig  4G) . In contrast, the expression of Epha4 and Efna5 was increased in the presence of the RAR inhibitor, BMS493, and suppressed by the RAR ligand, TTNPB (Fig 4H) , suggesting direct regulation by RAR. In a loss-of-function experiment, the addition of an anti-EFNA5 antibody prevented outgrowing of neurites and decreased their maximum length following stimulation by Aldh1a1 −/− media (Fig 4I) . Other parameters, such as total branch points, were not influenced by this treatment. These data suggest that complete Aldh1a1 −/− secretome is required to achieve full axonal growth efficiency, although EFNA5 contributes to the axon growth-promoting activity of Aldh1a1 −/− adipocytes. adipocytes could be used to stimulate innervation in vivo, we used a previously established model for testing encapsulated cells for metabolic disease treatment.
28,30
Semipermeable poly-L-lysine membrane allows encapsulated cells to exchange low-molecular-weight molecules (<36 kD). 28 Here, we used same model to study paracrine effects of axon guidance molecules because Efna5 gene encodes 26 kD protein.
We prepared equal concentrations of empty acellular capsules, encapsulated WT, as well as Aldh1a1 −/− adipocytes as previously described. 30 Host obese WT mice were treated using encapsulated WT adipocytes (control), Aldh1a1 −/− adipocytes, or acellular capsules (acellular control). Capsulates were injected into WAT of obese WT host mice study 3. After 80 days posttreatment, WAT were isolated and used for analysis of innervation. Encapsulated Aldh1a1 −/− adipocytes, but not WT adipocytes, stimulated the development of peripherin-positive axons around the capsules (Fig 5A) . Peripherin expression in WAT injected with encapsulated Aldh1a1 −/− adipocytes was significantly higher than in WAT injected with empty capsules (Fig 5B) . TH-positive sympathetic axons were also present around Aldh1a1 −/− capsules, but neither proximal or distal to encapsulated WT adipocytes (Fig 5C) . No detectable nerves were found in adipose tissue in nontreated obese mice or mice treated with acellular capsules. Mice treated with encapsulated Aldh1a1 −/− adipocytes had increased metabolic rate during the active (dark) period (Fig 6A) . This change was not due to differences in food consumption (Fig 6B) , as mice injected with encapsulated WT and Aldh1a1 −/− cells had similar food intake. The development of sympathetic innervation (Fig 6C) was associated with the formation of thermogenic uncoupling protein 1-positive adipocyte clusters in obese WT mice treated with encapsulated Aldh1a1 −/− adipocytes described previously. 28 No such effect was seen in control groups. Thus, paracrine effects from a subset of encapsulated Aldh1a1 −/− adipocytes promote functional innervation of WAT in vivo.
DISCUSSION
Our studies revealed a specific paracrine role of Aldh1a1 −/− adipocytes in the regulation of axon-guidance pathway molecules that support the induction of sympathetic innervation. Moreover, encapsulation of Aldh1a1 −/− adipocytes in alginate poly-L-lysine capsules is a viable strategy for boosting sympathetic innervation of WAT over a long period. Indeed, conditioned medium from Aldh1a1 −/− adipocytes has potent growth-promoting effects on neurites. Encapsulation of these adipocytes with subsequent transplantation into WAT maintains their growth-promoting potential on axones in vivo. Encapsulation technology has been previously developed for the implantation of pancreatic beta islet for insulin production. 43, 44 Here, we show that a subset of encapsulated cells with the engineered paracrine mechanism can alter the expression of multiple genes and orchestrate a complex innervation process. This technology holds the potential to stimulate axonal growth in translational settings for the treatment of metabolic neuropathies and, potentially, injuries and degenerative disease of the CNS.
Studies in animal models of obesity, as well as epidemiologic and clinical evidence, suggest a pathophysiologic relationship between neuropathy and metabolic syndrome. 45 Lipolysis and thermogenesis induction depend on a sensory and sympathetic circuit. 10, 11 Researchers have shown that lipid-storing adipocytes in WAT contribute to the production of axon-guiding molecules associated with obesity. 37, 46 Accordingly, the levels of these molecules, such as NGF 36, 37 and SEMA3A 46 are increased in obese patients. We provide evidence of another pathway in which Aldh1a1 −/− adipocytes produce distinct guidance cues for sensory axons and establish the inflow from WAT to the brain for the induction of sensory-sympathetic circuit and thermogenesis (Figs 5  and 6 ).
The key role of ALDH1A1 is in the production of RA from the precursor Rald with downstream activation of RAR in adipocytes. 20 We have shown that Rald can induce expression of Efna5/Epha4 genes. Conversely, conversion of Rald to RA activated RAR and reduced EFNA5 expression and secretion, Therefore, Efna5/Epha4 appear to be the primary target of vitamin A pathway that is responsible for innervation. It is possible that activated RAR also regulate other genes, such as Sema3e. Although multiple genes are involved in axonal guidance, RAR exerts the overall control over peripheral innervation. Inhibition of RAR ; and Robo1 and Slit2 (E) were measured in purified mRNA samples using a customized NanoString mouse panel including markers for adipogenesis, thermogenesis, and axon guidance genes. Data represent mean ± standard deviation (SD). An asterisk indicates P < 0.05; Mann Whitney U test. (F-H) 3T3-L1 adipocytes were cultured in differentiation medium for 4 d. At day 5, medium was replaced by UV-treated 1% fetal bovine serumcontaining DMEM with and without Rald (30 nM) (F), or with and without TTNPB (50 nM) or BMS493 (100 nM) (G and H). Then, 24 h post-stimulation, cells were harvested for mRNA. Gene expression was measured by the NanoString mouse innervation panel. Data (mean ± SD, n = 3) were normalized to the levels found in nontreated control (100%, dashed line). An asterisk indicates P < 0.05; Mann-Whitney U test. (I) Neuron growth indexes were obtained by XTI microscopy in DRG neurons cultured in DRG culture medium with or without NGF or in the Aldh1a1 −/− secretome (1/1, v/v) with and without blocking antibody against EFNA5 (1 μg/mL) for 24 h. RAR, retinoic acid receptor; WT, wild type; mRNA, messenger RNA; NGF, nerve growth factor; DRG, dorsal root ganglia. decreased neurogenesis, instead, increased EFNA5 expression, and secretion stimulated sensory-sympathetic innervation and adaptive thermogenesis. These responses place ALDH1A1 in a central regulatory position switching between lipogenic and thermogenic innervation in WAT. Peripherin was analyzed by Western blot in whole homogenized iAb WAT pads from mice in study 3. Bars show peripherin levels from the same tissues normalized to β-actin levels (n = 4). An asterisk indicates a significant difference between empty and Aldh1a1 −/− groups (P < 0.05; Mann-Whitney U test). (C) Immunohistochemical analysis of tyrosine hydroxylase (TH, brown) protein levels in axons of the animal groups in study 3. Note that TH-positive areas are found within nerves (40×) (red arrow) or in areas containing numerous multilocular adipocytes. WAT, white adipose tissue; WT, wild type; HF, high-fat; TH, tyrosine hydroxylase.
Several questions remain unanswered from our study. What types of cells are suitable for encapsulation technology and for guidance of specific neuron subtypes?
Many empirical studies have indicated that stem cells in adipose tissue can improve recovery from spinal cord injuries. 47 Other researchers have noted that implants of −/− adipocytes. Asterisk indicates statistically significant differences in metabolic rate during the dark period between treated groups (Wilcoxon-Mann-Whitney rank test, P < 0.05, n = 4). Food intake was not significantly different between the groups. (C) Immunohistochemical analysis of uncoupling protein 1 (UCP1) levels (marker of thermogenesis) in paraffin-embedded iAb fat from mice injected with vehicle, encapsulated WT, and encapsulated Aldh1a1 −/− cells at 20× magnification. Inserted figure shows the example of UCP-1 positive multilocular adipocytes at 40× magnification. These UCP-1 positive thermogenic multilocular adipocyte areas (blue arrows) were localized in proximity of nerves (red arrows). Right insert: Aldh1a1 −/− adipocytes inside capsules (indicated by C) also expressed UCP-1. WAT, white adipose tissue; WT, wild type; iAb, intra-abdominal or visceral fat. thermogenic beige and brown adipocyte become innervated, without explaining the mechanism of this phenomenon. 48 It is unclear if these cells play a paracrine role in innervations or differentiate precursor cells into neurons. Importantly, small populations of adipocytes in WAT can produce cues to promote de novo innervation and can be used for encapsulation technology. More research is needed to clarify the composition of molecules associated with axon guidance, which could include microRNA and/or metabolites. We did not investigate these molecules in the present study. Recent studies showed that AdamtS9 is a gene associated with sexual dimorphism in fat distribution 49 as well as susceptibility to type 2 diabetes in adults 50 and children. 51 Further studies are needed to elucidate if AdamtS9 supports the EFNA5/EPHA4 pathway of axon growth and if it contributes to the role of EFNA5 in obesity. The primary goal of this study was to prove that Aldh1a1 −/− adipocytes use a paracrine mechanism to induce axon growth in WAT. In vitro, the secretome of Aldh1a1 −/− adipocytes robustly induced neurite outgrowth in DRG neurons and its activity exceeded effects of the classic inducers, NGF and NT-3. In vivo, only encapsulated Aldh1a1 −/− adipocytes stimulated innervation in WAT of obese WT host mice. The nerves adjacent to encapsulated Aldh1a1 −/− adipocytes were peripherin-and TH-positive, indicating sympathetic innervation. This innervation was associated with increased NE secretion and converted adipocytes of obese WT animals into thermogenic uncoupling protein 1-positive multilocular adipocytes. This conversion increased the metabolic rate of treated animals. The thermogenic remodeling of host WAT occurred distally from capsules by means of the outgrowth of host TH-positive sympathetic neurons. Therefore, paracrine mediators from Aldh1a1 −/− adipocytes, acting via the sympathetic nerves system, have a higher capacity for thermogenic remodeling than stimulation of an intracellular thermogenic machinery in beige or brown adipocytes. This autonomous mechanism induced by encapsulated engineered cells offers an opportunity for treatment of obesity in a fat depot-specific manner.
